
ISPOR HEOR held a Theater focusing on discussions from the ISPOR HTA Roundtable – Middle East and Africa.
Presentations were provided by the World Health Organization, Rwanda School of Public Health, Ministry of Health of Tanzania, and Unified Procurement Authority of Egypt.
Recent Posts
Advancing EU Health Technology Assessment: Key Priorities in the HTACG Draft Annual Work Programm...
How will the EU Health Technology Assessment framework evolve in 2026 to improve clinical evaluations for cancer treatments and advanced therapies? The EU Health Technology Assessment (HTA) initiative coordinates standardized reviews of medicines and devices across Member States, thereby boosting...
Biomanufacturing Excellence Act: Strengthening U.S. Biopharmaceutical Manufacturing and Innovation
Launching the Biomanufacturing Excellence Act of 2025
The Biomanufacturing Excellence Act of 2025, introduced as H.R. 6089 in the 119th Congress on ...
Medicare Drug Price Negotiations: Major Savings for Seniors on Cancer and Chronic Disease Medicat...
Medicare drug price negotiations are transforming access to affordable healthcare for seniors, and if you're wondering how these negotiations will lower costs for high-expense cancer and chronic disease treatments, the answer is clear. Starting January 1, 2027, the Centers for Medicare & Medi...